Program Analysis
First-year earnings of $41,895 track close to the $48,121 national median for Biotechnology programs. This is a middle-of-the-road outcome on salary alone.
An earnings multiple of 2.6x means the program roughly breaks even in financial terms over ten years. Non-financial factors need to justify the investment.
AI risk is moderate — 48% task exposure — and the 11% scenario spread suggests disruption would dent but not destroy the earnings outlook.
The $23,937 debt-to-$41,895 income ratio translates to about 7 months of earnings. Standard loan terms should handle this comfortably.
At #18 out of 18 programs, Rochester Institute of Technology's financial outcomes for Biotechnology trail the majority of peers. The value case depends on other factors.
Earnings growth from $41,895 to $63,542 over five years (52% increase) indicates that graduates in this field see meaningful salary progression.